Form D Explorer
5D Patient Journey, Inc. · CIK 2122108

Report a data issueCitable research briefCompare issuerPrivate research collection

5D Patient Journey, Inc.

CIK 2122108 · Corporation · Inc. DELAWARE · NEW ROCHELLE, New York · Biotechnology

These Form D notices describe private placements reported to the SEC. Read Form D/A amendments alongside the original disclosures.

Filings
2
Original notices
2
Amendments
0
Activity
Mar 31, 2026
through Jun 18, 2026

Figures are issuer-reported and describe stored filings. Data coverage and methodology.

Differences between reported disclosures

Same issuer CIK; offering identity has not been established. Differences are arithmetic comparisons between disclosures, not additional capital raised, new investors or confirmed amendments to the same offering.

Unavailable values are shown as a dash; reported zero remains zero.
FieldMar 31, 2026 · DJun 18, 2026 · DLater minus earlier
Reported offering amount$80$6,017,471$6,017,391
Reported amount sold$80$5,460,004$5,459,924
Reported investor count—5—
Reported minimum investment$0$0$0

Earlier SEC source: 0002122108-26-000001 · Later SEC source: 0002122108-26-000002

Choose filings to compare · Research this issuer step by step

Latest available filing snapshot: how to read these fields

Form D · Jun 18, 2026

Reported offering amount
$6,017,471
Reported exemptions
Rule 506(b)
Reported amount sold
$5,460,004

This is one filing's disclosure, not the issuer's lifetime fundraising or current offering status.

Form D filings (2)